This is not the most recent version of the article. View current version (20 APR 2016)

Intervention Review

You have free access to this content

Sumatriptan plus naproxen for acute migraine attacks in adults

  1. Simon Law1,
  2. Sheena Derry2,*,
  3. R Andrew Moore2

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 21 OCT 2013

Assessed as up-to-date: 3 OCT 2013

DOI: 10.1002/14651858.CD008541.pub2


How to Cite

Law S, Derry S, Moore RA. Sumatriptan plus naproxen for acute migraine attacks in adults. Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD008541. DOI: 10.1002/14651858.CD008541.pub2.

Author Information

  1. 1

    Gloucester Hospitals NHS Foundation Trust, Department of Anaesthetics, Gloucestershire, UK

  2. 2

    University of Oxford, Pain Research and Nuffield Department of Clinical Neurosciences, Oxford, Oxfordshire, UK

*Sheena Derry, Pain Research and Nuffield Department of Clinical Neurosciences, University of Oxford, Pain Research Unit, Churchill Hospital, Oxford, Oxfordshire, OX3 7LE, UK. sheena.derry@ndcn.ox.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 21 OCT 2013

SEARCH

This is not the most recent version of the article. View current version (20 APR 2016)

[Figure 1]
Figure 1. Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
[Figure 2]
Figure 2. Forest plot of comparison: 1 Sumatriptan/naproxen versus placebo, outcome: 1.1 Pain-free at two hours.
[Figure 3]
Figure 3. L'Abbé plot showing results for sumatriptan + naproxen versus placebo for pain-free at two hours. Each circle represents a different study; blue circles are studies with moderate or severe baseline pain and cream circles are mild baseline pain; size of circle is proportional to size of study; diagonal is line of equivalence.
[Figure 4]
Figure 4. Forest plot of comparison: 1 Sumatriptan/naproxen versus placebo, outcome: 1.2 Headache relief at two hours.
[Figure 5]
Figure 5. L'Abbé plot showing results for sumatriptan + naproxen versus placebo for headache relief at two hours in studies with moderate or severe baseline pain. Each circle represents a different study; size of circle is proportional to size of study; diagonal is line of equivalence.
[Figure 6]
Figure 6. L'Abbé plot showing results for sumatriptan + naproxen versus placebo for 24-hour sustained pain-free. Each circle represents a different study; blue circles are studies with moderate or severe baseline pain and cream circles are mild baseline pain; size of circle is proportional to size of study; diagonal is line of equivalence.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Sumatriptan/naproxen versus placebo, Outcome 1 Pain-free at 2 h.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Sumatriptan/naproxen versus placebo, Outcome 2 Headache relief at 2 h.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Sumatriptan/naproxen versus placebo, Outcome 3 24-h sustained pain-free.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Sumatriptan/naproxen versus placebo, Outcome 4 24-h sustained headache relief.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Sumatriptan/naproxen versus placebo, Outcome 5 Any adverse event.
[Analysis 1.6]
Analysis 1.6. Comparison 1 Sumatriptan/naproxen versus placebo, Outcome 6 Rescue medication.
[Analysis 1.7]
Analysis 1.7. Comparison 1 Sumatriptan/naproxen versus placebo, Outcome 7 Relief of associated symptoms at 2 h.
[Analysis 1.8]
Analysis 1.8. Comparison 1 Sumatriptan/naproxen versus placebo, Outcome 8 Relief of functional disability at 2 h.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Sumatriptan/naproxen versus sumatriptan alone, Outcome 1 Pain-free at 2 h.
[Analysis 2.2]
Analysis 2.2. Comparison 2 Sumatriptan/naproxen versus sumatriptan alone, Outcome 2 Headache relief at 2 h.
[Analysis 2.3]
Analysis 2.3. Comparison 2 Sumatriptan/naproxen versus sumatriptan alone, Outcome 3 24-h sustained pain-free.
[Analysis 2.4]
Analysis 2.4. Comparison 2 Sumatriptan/naproxen versus sumatriptan alone, Outcome 4 24-h sustained headache relief.
[Analysis 2.5]
Analysis 2.5. Comparison 2 Sumatriptan/naproxen versus sumatriptan alone, Outcome 5 Any adverse event.
[Analysis 2.6]
Analysis 2.6. Comparison 2 Sumatriptan/naproxen versus sumatriptan alone, Outcome 6 Rescue medication.
[Analysis 2.7]
Analysis 2.7. Comparison 2 Sumatriptan/naproxen versus sumatriptan alone, Outcome 7 Relief of associated symptoms at 2 h.
[Analysis 2.8]
Analysis 2.8. Comparison 2 Sumatriptan/naproxen versus sumatriptan alone, Outcome 8 Relief of functional disability at 2 h.
[Analysis 3.1]
Analysis 3.1. Comparison 3 Sumatriptan/naproxen versus naproxen alone, Outcome 1 Pain-free at 2 h.
[Analysis 3.2]
Analysis 3.2. Comparison 3 Sumatriptan/naproxen versus naproxen alone, Outcome 2 Headache relief at 2 h.
[Analysis 3.3]
Analysis 3.3. Comparison 3 Sumatriptan/naproxen versus naproxen alone, Outcome 3 24-h sustained pain-free.
[Analysis 3.4]
Analysis 3.4. Comparison 3 Sumatriptan/naproxen versus naproxen alone, Outcome 4 24-h sustained headache relief.
[Analysis 3.5]
Analysis 3.5. Comparison 3 Sumatriptan/naproxen versus naproxen alone, Outcome 5 Any adverse event.
[Analysis 3.6]
Analysis 3.6. Comparison 3 Sumatriptan/naproxen versus naproxen alone, Outcome 6 Rescue medication.
[Analysis 3.7]
Analysis 3.7. Comparison 3 Sumatriptan/naproxen versus naproxen alone, Outcome 7 Relief of associated symptoms at 2 h.
[Analysis 3.8]
Analysis 3.8. Comparison 3 Sumatriptan/naproxen versus naproxen alone, Outcome 8 Relief of functional disability at 2 h.